{
    "organizations": [],
    "uuid": "ca323f4ecb2638faf8a60787a465e1f4869f04e1",
    "author": "",
    "url": "https://www.reuters.com/article/brief-strongbridge-biopharma-announces-p/brief-strongbridge-biopharma-announces-pricing-of-public-offering-idUSASB0C2IY",
    "ord_in_thread": 0,
    "title": "BRIEF-Strongbridge Biopharma Announces Pricing Of Public Offering",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 25 (Reuters) - Strongbridge Biopharma Plc:\n* STRONGBRIDGE BIOPHARMA PLC ANNOUNCES PRICING OF PUBLIC OFFERING OF ORDINARY SHARES\n* STRONGBRIDGE BIOPHARMA PLC SAYS PRICED ITS UNDERWRITTEN PUBLIC OFFERING OF 5 MILLION ORDINARY SHARES AT A PRICE TO PUBLIC OF $6.75 PER SHARE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-26T02:41:00.000+02:00",
    "crawled": "2018-01-26T02:56:47.018+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "strongbridge",
        "biopharma",
        "plc",
        "strongbridge",
        "biopharma",
        "plc",
        "announces",
        "pricing",
        "public",
        "offering",
        "ordinary",
        "share",
        "strongbridge",
        "biopharma",
        "plc",
        "say",
        "priced",
        "underwritten",
        "public",
        "offering",
        "million",
        "ordinary",
        "share",
        "price",
        "public",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}